Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115508) titled 'Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic profile of KLA578-1 for injection in healthy subjects after single/multiple administration' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: The Third Xiangya Hospital Central South University
Condition:
Postoperative pain
Intervention:
Group 2 (etoracoxib group):Administration of control drug "etocoxib tablet"
Multiple dose group:Administration of the experimental drug "KLA578-1 for injection" 120mg
Group 2 (KLA578-1 group for injection):Administration of the experimental drug "KLA57...